Drug Discovery and Development Analysis & Statistics in North America Countries, November 2014

You might be interested in: Clinical Trial, Drug Discovery, Drug Development, more »

1-50 of about 400 reports

Purchase Reports From Reputable Market Research Publishers

Discovery Stage Partnering Terms and Agreements

Discovery Stage Partnering Terms and Agreements

  • $ 3 295
  • Industry report
  • September 2014
  • by Currentpartnering

Provides comprehensive understanding and unprecedented access to the discovery stage partnering agreements entered into by the worlds leading biopharma companies The Discovery Stage Partnering Terms and ...

  • Industries : Drug Discovery and Development
  • Countries : United States

Barbados Total Clinical Trials

  • $ 250
  • Industry data
  • January 2013

Yearly, From January 01, 2009 To January 01, 2009
By Business Monitor International
Source: ClinicalTrials.gov, BMI. N.B. Sourced by date of initial registration.

  • Industries : Drug Discovery and Development
  • Countries : Barbados
Drug Discovery Technologies - A Global Market Overview

Drug Discovery Technologies - A Global Market Overview

  • $ 3 060
  • Industry report
  • August 2014
  • by Industry Experts

The development of new drugs for treating difficult diseases, such as cancer requires extensive expenditure, in addition to consuming a lot of time. The first step in designing a new drug involves the ...

  • Industries : Drug Discovery and Development
  • Countries : World, United States
Kawasaki Disease Global Clinical Trials Review, H2, 2014

Kawasaki Disease Global Clinical Trials Review, H2, 2014

  • $ 2 500
  • Industry report
  • October 2014
  • by Global Data

Kawasaki Disease Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, “Kawasaki Disease Global Clinical Trials Review, H2, 2014" provides data on the Kawasaki Disease clinical ...

  • Industries : Drug Discovery and Development
  • Countries : World, United States
Chediak-Higashi Syndrome Global Clinical Trials Review, H2, 2014

Chediak-Higashi Syndrome Global Clinical Trials Review, H2, 2014

  • $ 2 500
  • Industry report
  • October 2014
  • by Global Data

Chediak-Higashi Syndrome Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, “Chediak-Higashi Syndrome Global Clinical Trials Review, H2, 2014" provides data on the Chediak-Higashi ...

  • Industries : Drug Discovery and Development
  • Countries : United States, World
Lambert-Eaton Myasthenic Syndrome (LEMS) Global Clinical Trials Review, H2, 2014

Lambert-Eaton Myasthenic Syndrome (LEMS) Global Clinical Trials Review, H2, 2014

  • $ 2 500
  • Industry report
  • October 2014
  • by Global Data

Lambert-Eaton Myasthenic Syndrome (LEMS) Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, “Lambert-Eaton Myasthenic Syndrome (LEMS) Global Clinical Trials Review, H2, ...

  • Industries : Drug Discovery and Development
  • Countries : World, United States
Lung Transplantation Global Clinical Trials Review, H2, 2014

Lung Transplantation Global Clinical Trials Review, H2, 2014

  • $ 2 500
  • Industry report
  • October 2014
  • by Global Data

Lung Transplantation Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, “Lung Transplantation Global Clinical Trials Review, H2, 2014" provides data on the Lung Transplantation ...

  • Industries : Drug Discovery and Development
  • Countries : World, United States
Wiskott-Aldrich Syndrome Global Clinical Trials Review, H2, 2014

Wiskott-Aldrich Syndrome Global Clinical Trials Review, H2, 2014

  • $ 2 500
  • Industry report
  • October 2014
  • by Global Data

Wiskott-Aldrich Syndrome Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, “Wiskott-Aldrich Syndrome Global Clinical Trials Review, H2, 2014" provides data on the Wiskott-Aldrich ...

  • Industries : Drug Discovery and Development
  • Countries : World, United States
Mucopolysaccharidosis II (MPS II) (Hunter Syndrome) Global Clinical Trials Review, H2, 2014

Mucopolysaccharidosis II (MPS II) (Hunter Syndrome) Global Clinical Trials Review, H2, 2014

  • $ 2 500
  • Industry report
  • September 2014
  • by Global Data

Mucopolysaccharidosis II (MPS II) (Hunter Syndrome) Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, “Mucopolysaccharidosis II (MPS II) (Hunter Syndrome) Global Clinical ...

  • Industries : Drug Discovery and Development
  • Countries : World, United States
Peripheral Artery Occlusive Disease (PAOD) Global Clinical Trials Review, H2, 2014

Peripheral Artery Occlusive Disease (PAOD) Global Clinical Trials Review, H2, 2014

  • $ 2 500
  • Industry report
  • September 2014
  • by Global Data

Peripheral Artery Occlusive Disease (PAOD) Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, “Peripheral Artery Occlusive Disease (PAOD) Global Clinical Trials Review, ...

  • Industries : Drug Discovery and Development
  • Countries : World, United States
Hot Flashes Global Clinical Trials Review, H2, 2014

Hot Flashes Global Clinical Trials Review, H2, 2014

  • $ 2 500
  • Industry report
  • September 2014
  • by Global Data

Hot Flashes Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, “Hot Flashes Global Clinical Trials Review, H2, 2014" provides data on the Hot Flashes clinical trial scenario. ...

  • Industries : Drug Discovery and Development
  • Countries : World, United States
Proliferative Vitreoretinopathy (PVR) - Pipeline Review, H2 2014

Proliferative Vitreoretinopathy (PVR) - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • November 2014
  • by Global Markets Direct

Proliferative Vitreoretinopathy (PVR) - Pipeline Review, H2 2014 Summary Global Markets Direct's, ‘Proliferative Vitreoretinopathy (PVR) - Pipeline Review, H2 2014', provides an overview of the Proliferative ...

  • Industries : Drug Discovery and Development
  • Countries : World, United States
High Triglyceridemia - Pipeline Review, H2 2014

High Triglyceridemia - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • October 2014
  • by Global Markets Direct

High Triglyceridemia - Pipeline Review, H2 2014 Summary Global Markets Direct's, ‘High Triglyceridemia - Pipeline Review, H2 2014', provides an overview of the High Triglyceridemia's therapeutic pipeline. ...

  • Industries : Drug Discovery and Development
  • Countries : World, United States
Pituitary ACTH Hypersecretion (Cushing%s Disease) - Pipeline Review, H2 2014

Pituitary ACTH Hypersecretion (Cushing%s Disease) - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • October 2014
  • by Global Markets Direct

Pituitary ACTH Hypersecretion (Cushing's Disease) - Pipeline Review, H2 2014 Summary Global Markets Direct's, ‘Pituitary ACTH Hypersecretion (Cushing's Disease) - Pipeline Review, H2 2014', provides ...

  • Industries : Drug Discovery and Development
  • Countries : World, United States
Paroxysmal Nocturnal Hemoglobinuria - Pipeline Review, H2 2014

Paroxysmal Nocturnal Hemoglobinuria - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • September 2014
  • by Global Markets Direct

Paroxysmal Nocturnal Hemoglobinuria - Pipeline Review, H2 2014 Summary Global Markets Direct's, ‘Paroxysmal Nocturnal Hemoglobinuria - Pipeline Review, H2 2014', provides an overview of the Paroxysmal ...

  • Industries : Drug Discovery and Development
  • Countries : United States, World
Dystonia - Pipeline Review, H2 2014

Dystonia - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • September 2014
  • by Global Markets Direct

Dystonia - Pipeline Review, H2 2014 Summary Global Markets Direct's, ‘Dystonia - Pipeline Review, H2 2014', provides an overview of the Dystonia's therapeutic pipeline. This report provides comprehensive ...

  • Industries : Drug Discovery and Development
  • Countries : World, United States
Neutropenia - Pipeline Review, H2 2014

Neutropenia - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • August 2014
  • by Global Markets Direct

Neutropenia - Pipeline Review, H2 2014 Summary Global Markets Direct's, ‘Neutropenia - Pipeline Review, H2 2014', provides an overview of the Neutropenia's therapeutic pipeline. This report provides ...

  • Industries : Drug Discovery and Development
  • Countries : United States, World
Pathology in United States: Teikoku Pharma USA, Inc. – Product Pipeline Review – H2 2011

Pathology in United States: Teikoku Pharma USA, Inc. – Product Pipeline Review – H2 2011

  • $ 1 500
  • Company report
  • September 2014
  • by Global Markets Direct

- Product Pipeline Review - H2 2011” provides a detailed overview on the Teikoku Pharma USA, Inc.’s research and development focus. The report includes data on current developmental pipeline, complete ...

  • Industries : Drug Discovery and Development
  • Countries : United States
Endoscape, Inc. - Product Pipeline Analysis, 2014 Update

Endoscape, Inc. - Product Pipeline Analysis, 2014 Update

  • $ 750
  • Company report
  • October 2014
  • by Global Data

Summary Endoscape, Inc. (Endoscape) is a medical device company. The company provides products for colon cancer screening. It offers products such as colon intubation assist device, advanced angulation ...

  • Industries : Drug Discovery and Development
  • Countries : United States
MicroVention, Inc. - Product Pipeline Analysis, 2014 Update

MicroVention, Inc. - Product Pipeline Analysis, 2014 Update

  • $ 750
  • Company report
  • September 2014
  • by Global Data

Summary MicroVention, Inc. (MicroVention) is a medical device company. The company develops catheter based technologies for the endovascular treatment of peripheral and cerebral vascular diseases. Its ...

  • Industries : Drug Discovery and Development
  • Countries : United States, Costa Rica, North America, Canada, France, Germany, Japan
Electrical Geodesics, Inc. (EGI) - Product Pipeline Analysis, 2014 Update

Electrical Geodesics, Inc. (EGI) - Product Pipeline Analysis, 2014 Update

  • $ 750
  • Company report
  • September 2014
  • by Global Data

Summary Electrical Geodesics, Inc. (EGI) is a medical device company. The company operates through divisions such as clinical division, research division and neuroinformatics division. It offers clinical ...

  • Industries : Drug Discovery and Development
  • Countries : United States
GI Dynamics, Inc. (GID) - Product Pipeline Analysis, 2014 Update

GI Dynamics, Inc. (GID) - Product Pipeline Analysis, 2014 Update

  • $ 750
  • Company report
  • September 2014
  • by Global Data

Summary GI Dynamics, Inc. (GI Dynamics) is a medical device company. The company develops and commercializes non-surgical treatments for the global patient population suffering with type 2 diabetes and ...

  • Industries : Drug Discovery and Development
  • Countries : United States
Avastra Sleep Centres Limited - Strategic SWOT Analysis Review

Avastra Sleep Centres Limited - Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • November 2014
  • by Global Data

Summary Avastra Sleep Centres Limited (Avastra) is a publicly held Australia based company that operates diagnostic sleep centers. It is one of the largest networks of sleep specialists in the US. The ...

  • Industries : Drug Discovery and Development
  • Countries : Australia, United States
PharmaGap Inc. (Symbol:GAP) SWOT Analysis, Strategy, Revenues and Profits

PharmaGap Inc. (Symbol:GAP) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Drug Discovery and Development
  • Countries : Canada
MIGENIX Inc. (BWESF) - Strategic SWOT Analysis Review

MIGENIX Inc. (BWESF) - Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • November 2014
  • by Global Data

Summary MIGENIX Inc. (MIGENIX), formerly known as Micrologix Biotech Inc., is a publicly held bio-pharmaceutical company. It is principally engaged in researching, developing and commercializing drugs ...

  • Industries : Drug Discovery and Development
  • Countries : Canada
Almac Group Limited SWOT Analysis, Strategy, Revenues and Profits

Almac Group Limited SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Drug Discovery and Development
  • Countries : United States
Amazon BioTech - Strategic SWOT Analysis Review

Amazon BioTech - Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • November 2014
  • by Global Data

Summary Amazon BioTech (Amazon) is a pharmaceutical company. The company researches and develops natural drugs for the treatment of HIV disease based on immune-based therapies. It's AMZ0026 - Amazon Biotech's ...

  • Industries : Drug Discovery and Development
  • Countries : United States
Bruker Daltonics Inc. SWOT Analysis, Strategy, Revenues and Profits

Bruker Daltonics Inc. SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Drug Discovery and Development
  • Countries : United States
Cadus Corporation (Symbol:KDUS) SWOT Analysis, Strategy, Revenues and Profits

Cadus Corporation (Symbol:KDUS) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Drug Discovery and Development
  • Countries : United States
FASgen, Inc. SWOT Analysis, Strategy, Revenues and Profits

FASgen, Inc. SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Drug Discovery and Development
  • Countries : United States
NewBiotics, Inc. SWOT Analysis, Strategy, Revenues and Profits

NewBiotics, Inc. SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Drug Discovery and Development
  • Countries : United States

17 Companies

Read our Company Profiles

GlaxoSmithKline P.L.C.

United States

Pfizer Inc.

United States

General Hospital Corp.

United States

Novartis Inc.

Switzerland

GlaxoSmithKline PLC

United Kingdom

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.